Seagen saw the highest growth of 123% in patent filings and 699% in grants in August in Q3 2023. Compared to Q2 2023, Q3 2023 saw an increase in patent filings by 70% and grants by 24%. GlobalData’s DataBook provides a comprehensive analysis of Seagen‘s patent filings and grants. Buy the databook here.
Seagen has been focused on protecting inventions in European Patent Office(EPO) with 12 publications in Q3 2023
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 17% filings and 8% grants. The United States(US), European Patent Office(EPO), South Korea(KR), and Israel(IL) patent Office are among the top ten patent offices where Seagen is filings its patents. Among the top granted patent authorities, Seagen has 15% of its grants in United States(US), 15% in Australia(AU), and 8% in European Patent Office(EPO).
Johnson & Johnson could be the strongest competitor for Seagen
Johnson & Johnson and Pfizer secured the top positions according to recent patent publication data.
Patents related to rare diseases and climate change lead Seagen's portfolio
Seagen has the highest number of patents in rare diseases followed by, climate change and nanomedicine. For rare diseases, nearly 58% of patents were filed and 50% of patents were granted in Q3 2023.
Hodgkin lymphoma (b-cell hodgkin lymphoma) related patents lead Seagen portfolio followed by lymphoma, and non-hodgkin lymphoma
Seagen has highest number of patents in hodgkin lymphoma (b-cell hodgkin lymphoma) followed by lymphoma, non-hodgkin lymphoma, leukemia and multiple myeloma (kahler disease). For hodgkin lymphoma (b-cell hodgkin lymphoma), nearly 3% of patents were filed and 16% of patents were granted in Q3 2023.
For comprehensive analysis of Seagen's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.